Managing IBD Patients With Few Options Left

Originally published by our sister publication Gastroenterology & Endoscopy NewsBy Gina ShawLAS VEGAS—When patients with inflammatory bowel disease have cycled through multiple advanced therapies without achieving durable remission, clinical decision-making becomes less about standard sequencing and more about strategy, said experts at the 2026 Crohn’s & Colitis Congress. They emphasized that “few options” rarely means no options but does require reassessing disea